On February 11, there was still no trading in domestic phthalic anhydride market
Lead reading of phthalic anhydride: Yesterday, the domestic phthalic anhydride market still had no trading and investment, affected by the epidemic situation, the terminal industry has not recovered, the downstream plasticizer and resin industry delayed the start of construction, the transportation is also blocked, the inquiry and purchase of phthalic anhydride are rare, the latest statistics show that the inventory accumulation of phthalic anhydride industry is obvious, which depresses the mentality, and most of the industry is waiting for the market. Future forecast: traders have not yet entered the market, and trading will still be stagnant. It is expected that the focus will be reversed.
Anthracite up 30-130 yuan
2026-09-07
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
How To Make Acetic Anhydride From Acetic Acid? Carbonylation Process
-
DBP Market in Q1, 2017: Weaker-Than-Expected Demand
-
DBP Market in Q1, 2017: Weaker-Than-Expected Demand
-
Analysis of Import Data of Benzene Anhydride in China
-
Market Analysis - Monthly Report - June, 2020 - Phthalic Anhydride
-
Market Analysis - Monthly Report - June, 2020 - Phthalic Anhydride
-
Market Analysis - Monthly Report - June, 2020 - Maleic Anhydride
-
The trend of domestic phthalic anhydride market on April 20
-
The trend of domestic phthalic anhydride market on April 20
-
On April 16, the domestic phthalic anhydride market rose
Recommend Reading
-
Nestlé Drops Artificial Colors Worldwide by 2026: Food Additives Face a Reformulation Shock
-
U.S. Includes Lithium in National Defense Stockpile for First Time, Plans to Purchase 16,200 Tons Over Five Years
-
COIM Group Expands Alkyd and Acrylic Resin Production Capacity in the Netherlands
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
South Africa Wants Lenacapavir at Home, Not Just Imported
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
In September, China's BDO market remains weak
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
China's Acetone Market Drops to Year-to-date Low in September
-
Downstream Demand Releases, Formic Acid Prices Steadily Rise